QCM
IONS icon

Quantinno Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quantinno Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.15M Buy
64,914
+9,412
+17% +$708K 0.01% 1272
2026
Q1 		$4.17M Buy
55,502
+8,124
+17% +$641K 0.01% 1230
2025
Q4 		$3.75M Buy
47,378
+11,263
+31% +$848K 0.01% 1135
2025
Q3 		$2.36M Buy
36,115
+18,573
+106% +$907K 0.01% 1170
2025
Q2 		$693K Buy
17,542
+9,027
+106% +$295K ﹤0.01% 1457
2025
Q1 		$257K Buy
+8,515
New +$279K ﹤0.01% 1714

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quantinno Capital Management's IONS Position: Q2 2026 in Review

Quantinno Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 17% in Q2 2026, buying an estimated $708K and bringing the position to 64,914 shares worth $5.15M. The position accounts for 0.01% of the portfolio, ranked #1272.

Quantinno Capital Management first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Quantinno Capital Management held 64,914 shares of Ionis Pharmaceuticals worth $5.15M as of Q2 2026.
  • Quantinno Capital Management bought 9,412 Ionis Pharmaceuticals shares in Q2 2026, an estimated $708K.
  • Ionis Pharmaceuticals made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1272 holding.
  • Quantinno Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.